TER June 2018 LA1 - Self Study

TEACH Educational Rounds
Webinar Series

Self-Study Registration

Session: Smoking Cessation and Co-occurring Opioid Use

Date Presented: Wednesday June 27, 2018

Time: 12:00 PM - 1:00 PM EST

Faculty: Dr. Peter Selby, MBBS, CCFP, FCFP, MHSc, DipABAM, DFASAM

First Name:

* must provide value

Last Name:

* must provide value

E-mail address:

* must provide value

Confirm E-mail address:

* must provide value

Organization/Agency Name:

* must provide value

Organization Address:

* must provide value

City:

* must provide value

Province:

* must provide value

Postal/Zip Code:

* must provide value

In which sector do you primarily work?

* must provide value

Please indicate if you work for a/an:

* must provide value

What is your current discipline?

* must provide value

What region does your organization serve?

* must provide value

TEACH Educational Rounds Webinar Series:
Pre-Learning Assessment
June 27, 2018

This questionnaire is part 1 of 2 self-assessments of your learning in the TEACH Educational Rounds session
"Smoking Cessation and Opioid Use"

Please take a few moments to fill out this assessment before the session starts

Please note: registration/pre-learning assessment and post-learning assessment surveys, in addition to attending the full hour of the live webinar, are required in order to be eligible to receive a CAMH/TEACH letter of completion. This program has been reviewed by the College of Family Physicians of Canada and is awaiting final accreditation by the College's Ontario Chapter. This program has been accredited with the Royal College of Physicians and Surgeons of Canada (Royal College), MOC Program Section 1: Accredited Group Learning Credits.

We are interested in your self-assessment your knowledge and skills related to the webinar content, the feasibility, importance, and your confidence in using the various tools and interventions we will cover in this session, as well as getting a sense of the clinical activities in which you are currently engaged. This information will help guide future course development and help us to evaluate your pre-and-post ratings of key concepts.

Please rate and answer the following questions as they relate to the key learning objectives for this webinar

On a scale of 0 to 10, with 10 being the highest rating, rate your knowledge regarding the relationship between tobacco and opioid use.

* must provide value

On a scale of 0 to 10, with 10 being the highest rating, rate your skills in identifying the relationship between tobacco and opioid use.

* must provide value

On a scale of 0 to 10, with 10 being the highest rating, rate how feasible it is to identify the relationship between tobacco and opioid use.

* must provide value

On a scale of 0 to 10, with 10 being the highest rating, rate how important it is to identify the relationship between tobacco and opioid use.

* must provide value

On a scale of 0 to 10, with 10 being the highest rating, rate how confident you are at identifying the relationship between tobacco and opioid use.

* must provide value

Do you currently identify the relationship between tobacco and opioid use with your clients?

* must provide value

Yes

Not applicable

reset

On a scale of 0 to 10, with 10 being the highest rating, rate your knowledge regarding the harms associated with concurrent tobacco and opioid use.

* must provide value

On a scale of 0 to 10, with 10 being the highest rating, rate your skills in describing the harms associated with concurrent tobacco and opioid use.

* must provide value

On a scale of 0 to 10, with 10 being the highest rating, rate how feasible it is to describe the harms associated with concurrent tobacco and opioid use.

* must provide value

On a scale of 0 to 10, with 10 being the highest rating, rate how important it is to describe the harms associated with concurrent tobacco and opioid use.

* must provide value

On a scale of 0 to 10, with 10 being the highest rating, rate how confident you are at describing the harms associated with concurrent tobacco and opioid use.

* must provide value

Do you currently describe the harms associated with concurrent tobacco and opioid use with your clients?

* must provide value

Yes

Not applicable

reset

On a scale of 0 to 10, with 10 being the highest rating, rate your knowledge regarding treatment approaches that address concurrent tobacco and opioid use.

* must provide value

On a scale of 0 to 10, with 10 being the highest rating, rate your skills in describing treatment approaches that address concurrent tobacco and opioid use.

* must provide value

On a scale of 0 to 10, with 10 being the highest rating, rate how feasible it is to describe treatment approaches that address concurrent tobacco and opioid use.

* must provide value

On a scale of 0 to 10, with 10 being the highest rating, rate how important it is to describe treatment approaches that address concurrent tobacco and opioid use.

* must provide value

Do you currently describe treatment approaches that address concurrent tobacco and opioid use with your clients?

* must provide value

Yes

Not applicable

reset

You have selected an option that triggers this survey to end right now.

To save your responses and end the survey, click the 'End Survey' button below. If you have selected the wrong option by accident and/or wish to return to the survey, click the 'Return and Edit Response' button.